Information Provided By:
Fly News Breaks for August 2, 2018
HUM
Aug 2, 2018 | 07:45 EDT
RBC Capital analyst Frank Morgan raised his Humana price target to $318 after its Q2 results, saying the company "again exceeded expectations with solid membership growth and lower-than-expected medical costs". The analyst is also positive on the company's visibility and the management's initiative in the rollout of integrated care strategy, while "maintaining optionality" on partnership-driven strategic alignment. Morgan sees "significant tailwinds" supporting Humana's earnings growth, but keeps his Sector Perform rating given the valuation on the stock.
News For HUM From the Last 2 Days
There are no results for your query HUM